Lab tools & diagnostics
Instruments, supplies and testing services for labs, drugmakers and doctors.
एक AI मॉडल की मदद से समूहबद्ध और हमारे संपादकों द्वारा जाँचा गया। हर कंपनी के नीचे की पंक्ति बताती है कि वह यहाँ क्यों है।
शेयर मूल्य 11 नव॰ 2026 के समापन मूल्य हैं, IEX एक्सचेंज फ़ीड से।
Grade mix
A 8B 8C 2D 1F 1
Revenue growing
19 of 20
Free cash flow growing
9 of 20
Median price move, 1 year
+22.0%
- TMOTHERMO FISHER SCIENTIFIC INC.
Diagnostics and researchMarket cap $265.9BP/E 37.85
$717.62+22.5%1YSince added +8.2%
A+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- तेज़ हो रहा
- Business quality
- मज़बूत
- Getting better
- सुधर रही है
Revenue
$47.4B+8.3%Profit
$7.1B+7.6%Free cash flow
$7.6B+24.3%Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
- DHRDANAHER CORPORATION
Diagnostics and researchMarket cap $165.5BP/E 38.51
$235.31+8.0%1YSince added +5.4%
B+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- तेज़ हो रहा
- Business quality
- मज़बूत
- Getting better
- सुधर रही है
Revenue
$25.6B+5.5%Profit
$4.3B+23.6%Free cash flow
$5.7B+14.2%Why it is here: Sells research instruments, supplies and services
- AAGILENT TECHNOLOGIES, INC.
Diagnostics and researchMarket cap $49.9BP/E 34.89
$176.91+17.6%1YSince added +3.1%
B+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- तेज़ हो रहा
- Business quality
- मज़बूत
- Getting better
- सुधर रही है
Revenue
$7.4B+8.6%Profit
$1.4B+18.0%Free cash flow
$1.3B+16.5%Why it is here: Sells lab instruments, consumables and software to labs and drug makers
- WATWaters Corporation
Diagnostics and researchMarket cap $46.3BP/E 202.08
$470.84+21.5%1YSince added +9.7%
D- वृद्धि और नकदी
- बढ़ रही है
- Business trend
- धीमा हो रहा
- Business quality
- मिश्रित
- Getting better
- मिश्रित
Revenue
$5.6B+84.2%Profit
$98.6M-84.8%Free cash flow
$290.8M-51.7%Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
- MTDMettler-Toledo International Inc.
Diagnostics and researchMarket cap $34.8BP/E 37.95
$1,749.30+20.8%1YSince added +9.4%
B+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मज़बूत
- Getting better
- सुधर रही है
Revenue
$4.2B+6.5%Profit
$934.1M+11.8%Free cash flow
$870.6M-2.1%Why it is here: Makes precision laboratory instruments and weighing equipment
- ILMNIllumina, Inc.
Diagnostics and researchMarket cap $32.2BP/E 36.64
$212.86+74.5%1YSince added -21.5%
A+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मज़बूत
- Getting better
- तेज़ी से सुधर रही है
Revenue
$4.5B+5.8%Profit
$895M+27.5%Free cash flow
$1.1B+5.7%Why it is here: Sells DNA sequencing instruments and reagents
- IDXXIDEXX LABORATORIES INC /DE
Diagnostics and researchMarket cap $55.4BP/E 47.37
$703.00-1.5%1YSince added +35.2%
A+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मज़बूत
- Getting better
- तेज़ी से सुधर रही है
Revenue
$4.7B+11.9%Profit
$1.2B+15.1%Free cash flow
$1.3B+35.3%Why it is here: Sells veterinary diagnostic tests and instruments
- DGXQuest Diagnostics Inc
Diagnostics and researchMarket cap $28.5BP/E 25.77
$258.72+40.8%1YSince added +12.2%
A- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- ठोस
- Getting better
- सुधर रही है
Revenue
$11.8B+9.1%Profit
$1.1B+16.5%Free cash flow
$1.4B-1.3%Why it is here: Provides diagnostic testing and clinical lab services
- LHLABCORP HOLDINGS INC.
Diagnostics and researchMarket cap $30.2BP/E 30.53
$372.18+41.3%1YSince added +18.7%
A- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मिश्रित
- Getting better
- तेज़ी से सुधर रही है
Revenue
$14.6B+6.0%Profit
$1B+17.4%Free cash flow
$1.3B-6.8%Why it is here: Provides diagnostic tests and clinical lab services
- RVTYREVVITY, INC
Diagnostics and researchMarket cap $17.7BP/E 70.32
$158.22+68.5%1YSince added +2.0%
A- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मिश्रित
- Getting better
- सुधर रही है
Revenue
$2.9B+4.6%Profit
$253.2M+6.6%Free cash flow
$590.5M+18.7%Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
- IQVIQVIA HOLDINGS INC.
Diagnostics and researchMarket cap $45.2BP/E 33.38
$274.37+24.2%1YSince added +5.2%
A- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मिश्रित
- Getting better
- सुधर रही है
Revenue
$17.3B+8.8%Profit
$1.4B+8.7%Free cash flow
$2.1B-6.0%Why it is here: Runs clinical trials and sells healthcare data to drugmakers
- NTRANATERA, INC.
Diagnostics and researchMarket cap $46.4BP/E नहीं (परिचालन घाटा)
$319.77+52.6%1YSince added -19.2%
B-- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- कमज़ोर
- Getting better
- मिश्रित
Revenue
$2.9B+37.4%Profit
-$164.7M+46.7%Free cash flow
$52.5M-50.5%Why it is here: Provides genetic and cell-free DNA diagnostic tests
- TECHBIO-TECHNE Corp
BiotechnologyMarket cap $11.4BP/E 66.77
$72.78+19.2%1YSince added +0.4%
A+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- तेज़ हो रहा
- Business quality
- मज़बूत
- Getting better
- तेज़ी से सुधर रही है
Revenue
$1.2B+0.9%Profit
$172M+120.5%Free cash flow
$308.2M+37.6%Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
- BRKRBRUKER CORPORATION
Medical devicesMarket cap $9.5BP/E नहीं (परिचालन घाटा)
$62.41+47.5%1YSince added +11.0%
B- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- धीमा हो रहा
- Business quality
- मिश्रित
- Getting better
- मिश्रित
Revenue
$3.5B+2.2%Profit
-$123.4M-490.4%Free cash flow
$244.7M+2,408.5%Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
- RGENREPLIGEN CORP
Medical instruments and suppliesMarket cap $9.8BNo P/E
$172.68+9.3%1YSince added -1.6%
B- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- धीमा हो रहा
- Business quality
- मिश्रित
- Getting better
- सुधर रही है
Revenue
$805.6M+13.8%Profit
-$11.8M-779.2%Free cash flow
$106.7M-3.0%Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
- BIOBIO-RAD LABORATORIES, INC.
Medical devicesMarket cap $10.4BP/E नहीं (परिचालन घाटा)
$386.08+18.0%1YSince added +6.1%
C- वृद्धि और नकदी
- बढ़ रही है
- Business trend
- स्थिर
- Business quality
- ठोस
- Getting better
- सुधर रही है
Revenue
$2.6B+1.4%Profit
$1B+251.3%Free cash flow
$329.1M-2.3%Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
- QGENQIAGEN N.V.
Diagnostics and researchMarket cap $10.9BP/E 25.93
$50.30+19.8%1YSince added +10.7%
B+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मज़बूत
- Getting better
- सुधर रही है
Revenue
$2.1B+2.1%Profit
$384.5M-5.2%Free cash flow
$436.2M-8.9%Why it is here: Supplies sample preparation and molecular testing kits and instruments
- GHGUARDANT HEALTH, INC.
Diagnostics and researchMarket cap $20.9BP/E नहीं (परिचालन घाटा)
$154.76+58.2%1YSince added -4.5%
B- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- स्थिर
- Business quality
- मिश्रित
- Getting better
- मिश्रित
Revenue
$1.3B+41.7%Profit
-$485.1M-21.6%Free cash flow
-$232.1M+11.5%Why it is here: Provides blood-based cancer diagnostic tests
- MEDPMedpace Holdings, Inc.
Diagnostics and researchMarket cap $18.6BP/E 36.90
$664.52+11.2%1YSince added +9.0%
C+- वृद्धि और नकदी
- मज़बूती से बढ़ रही है
- Business trend
- धीमा हो रहा
- Business quality
- मज़बूत
- Getting better
- तेज़ी से सुधर रही है
Revenue
$2.8B+20.4%Profit
$517.8M+19.6%Free cash flow
$667.6M-1.4%Why it is here: Runs clinical trials for biotech and pharma drug developers
- CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Diagnostics and researchMarket cap $16.4BP/E 353.20
$342.61+99.8%1YSince added +14.5%
F- वृद्धि और नकदी
- मिश्रित
- Business trend
- सिकुड़ रहा
- Business quality
- मिश्रित
- Getting better
- मिश्रित
Revenue
$4B-1.2%Profit
$40.2M+148.8%Free cash flow
$399.6M-26.5%Why it is here: Provides preclinical research models and testing services to drug developers
Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.
Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.
DiscussionNo comments yet
Be civil and stick to the companies. Comments are opinions, not advice.